After three rounds of collection, foreign enterprises can't stay?

Guide: It seems that sales growth is as strong as a tiger, in fact, it counts as a profit of two gross fiveSince November 2018, the pharmaceutical industry has been "in full war" under the round-robin bombardment of the 4 plus 7, the cluster and the second batch of harvestingThere are pharmaceutical companies to take the volume of procurement to make a summary of "seemingly sales growth as a tiger, in fact, calculate the profit of two gross five."2020 is nearly half, from April the National Health Care Administration out of the document is not difficult to predict that the third round of volume procurement will arrive as scheduledSome analysts believe that the third round of tape procurement may start in JulyAt that time from the second batch of centralized procurement only half a year, more frequent collection or show one thing: the volume of procurement of "war" not only will not stop, but become more and more intensejudging from the past in-laws, drugs that evaluate more through consistency will still be the focus of collectionAt present, at least 70 kinds of drugs have three or more over the evaluation of enterprises, put aside the previous two batches of varieties, metformin hydrochloric acid, tetracello tablets, catoply tablets, apixaban tablets and other drugs a big probability of being shortlisted in this collection catalogon the other hand, the injection consistency evaluation officially beganOn May 14, the State Drug Administration issued the "Announcement on the Evaluation of the Quality and Efficacy of Generic Chemical Injections", which requires all generic chemical injections to be evaluated for consistencyConsistency evaluation and band procurement as a set of combined fists, is expected to injectable band procurement or in the near future spread throughout the countrythe industry changes followed, the medical people exactly where to go, this question is worth thinking deeply(a) jump or not?under the double whammy of the epidemic and volume procurement, the profits of some varieties have shrunk sharply, leading to some pharmaceutical permembers to reduce their salaries or lose their jobsIn September 2019, Beijing Jialin Pharmaceuticals Atorvastatin calcium products "Ale" in the collection of expansion, immediately disbanded the sales teamThere are also pharmaceutical companies in the rapid "change" in the outbreak of the sales department, from the direct mode to the service outsourcing of the investment model, which means that the direct representative to "small package", the base salary and five risks of a gold gonevolatile environment seiswells frequent job changes, but frequent job-hopping are often seen as low loyaltyTherefore, for job-hopping, should be judged from two dimensions, one is the income from work, the other is the fun of workif the income is good and the fun is enough, there is no need to jump shipMoreover, frequent job-hopping is not beneficial to promotion, as companies generally tend to promote internallyYoung people should be calm, do not encounter a little difficulty and then rush to jump shipIf there is a better chance, the general representative level jumps for 2 years, the manager level moves once in 3-4 years, and the regional level bounces more cautious(2) There are great differences between foreign or domestic enterprises
the management system, operating mechanism and corporate culture of foreign enterprises and domestic enterprisesthe characteristics of foreign enterprises are sound organizational system, perfect training mechanism, and clear path of promotionA sound training mechanism is extremely friendly for new people, a sound organizational mechanism allows employees to perform their own duties, but the shortcomings are also very obvious, the lack of change in the regular work, limited and repetitive matters lead to limited income growthand the biggest feature of domestic enterprises is flexibility, from the content of the work to the cost are highlighted a high degree of flexibility, income also varies from person to person, especially suitable for a certain degree of experience, more ideas of employeesmany people yearn for foreign enterprises, but from the current volatile situation, foreign enterprises are not necessarily "good wood", domestic capital is not necessarily "decaywood", so there is no need to be too tied to the choice of domestic and foreign enterprisesThe congested pipeline is more worthy of choice, such as the current research and development pipeline hot PD-1, PARP inhibitors and other areas are excellent employment options, the future with the launch of new research and development products, is bound to trigger a huge demand for talentNovember 2019, Baiotaa Adamu single anti-anti-listing, the company invested a lot of money to form a sales teamWith the introduction of innovative drugs in China, good at the field of cancer drugs to promote the representative or will be "scented."(iii) medical devicesthe pharmaceutical industry", many pharmaceutical people will look to the field of medical devices From a policy point of view, medical device changes are indeed small, but the conclusion that medical devices are easier than medicine to make money is not necessarily too hasty is that the medical device market has a small capacity According to CMH data, china's pharmaceutical market in 2019 reached 173.92 billion yuan, compared with 355.5 billion yuan in the pharmaceutical equipment market, the former is five times the latter, which means that from the point of view of demand, the pharmaceutical industry demand for talent is much larger than medical devices second is the long process of large-scale medical devices in hospital Large-scale medical equipment in addition to provincial or municipal standards, each hospital also has a "hospital standard", need to represent a hospital ground grinding third, small and medium-sized medical devices and pharmaceutical market is equally competitive With syringes, blood vessels, B super and other medical device registration certificate of more than a hundred enterprises, homogenized products lead to enterprises only move the idea of marketing, in the inevitable price war greatly reduced the profits of enterprises (4) Internet medical from 2012 by the capital wind pushed to the high ground, to 2016 was hit to the ground, to 2020 encountered the development of the opportunity of the epidemic, Internet health care can be described as a roller coaster-style madness In several rounds of wind, a group of medical permens poured into the Internet medical However, the lost profit model has always been a pain point in Internet healthcare Call not to call for this plate again appropriate, ultra-high "flow" and super bad "cash flow" so that many people are discouraged For such emerging areas, it is recommended to think twice and move on